SCHEMBL23355170

SCHEMBL23355170

CC(NC(=O)c1c(Cl)cccc1Cl)C(=O)c1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TYK2 P29597 2/20 0.45
JAK2 O60674 1/20 0.45
PSMB5 P28074 1/20 0.44
PPIA P62937 1/20 0.43
ALDH1A1 P00352 2/20 0.43
GPR55 Q9Y2T6 1/20 0.43
SLC6A2 P23975 2/20 0.42
CHRNA1 P02708 1/20 0.42
CHRNG P07510 1/20 0.42
ITGA5 P08648 1/20 0.42
CHRNB1 P11230 1/20 0.42
CHRNB2 P17787 1/20 0.42
CHRNB4 P30926 1/20 0.42
SLC6A4 P31645 1/20 0.42
CHRNA3 P32297 1/20 0.42
CYP2C19 P33261 1/20 0.42
HRH1 P35367 1/20 0.42
CHRNA7 P36544 1/20 0.42
OPRK1 P41145 1/20 0.42
CHRNA4 P43681 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23355189 0.90 ITGB1 (0.43) TYK2JAK2PSMB5ALDH1A1GPR55
SCHEMBL14500982 0.83 PYGL (0.49) PSMB5SLC6A3ITGB1ITGA4ITGA2
SCHEMBL5700509 0.81 SMN1; SMN2 (0.54) ALDH1A1SMN1; SMN2MAPT
SCHEMBL23355178 0.81 ITGB2 (0.48) PSMB5PPIAITGA4SMN1; SMN2ITGB2
SCHEMBL30695663 0.79 GAA (0.54) ALDH1A1GPR55KCNH2KDM4E
SCHEMBL8804032 0.79 ITGB2 (0.46) TYK2JAK2PSMB5ALDH1A1ITGB1
SCHEMBL11056940 0.78 ALDH1A1 (0.49) TYK2JAK2PSMB5ALDH1A1ITGB1
SCHEMBL12020093 0.78 MAPT (0.48) ALDH1A1ITGB1ITGA4KDM4EMAPT
SCHEMBL23355193 0.76 ITGA4 (0.48) ITGB1ITGA4SMN1; SMN2ITGB2ICAM1
SCHEMBL23355181 0.76 NPC1 (0.40) ALDH1A1SLC6A2CHRNA1CHRNGITGA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3820864-A1 METHODS OF TREATING LIVER FIBROSIS USING CALPAIN INHIBITORS Blade Therapeutics, Inc. (US) 2021-05-19 EP disclosed